Long-term outcomes with adjuvant CDK4/6 inhibitors: who benefits most?

Saved in:
Bibliographic Details
Title: Long-term outcomes with adjuvant CDK4/6 inhibitors: who benefits most?
Authors: O'Meara, T.A.1 (AUTHOR), Burstein, H.J.1 (AUTHOR) Hal_burstein@dfci.harvard.edu
Source: Annals of Oncology. Feb2026, Vol. 37 Issue 2, p133-135. 3p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.10.012